Wei Liang | Healthcare Data Analysis | Best Researcher Award

Dr. Wei Liang | Healthcare Data Analysis | Best Researcher Award

Doctorate at East China University of Science and Technology, China

 Author Profile 👨‍🎓

Early Academic Pursuits 🎓

Dr. Wei Liang embarked on his academic journey at East China University of Science and Technology, where he earned his Bachelor’s degree in Engineering (B.E.) in 2020. His interest in Brain-Computer Interfaces (BCI) and Machine Learning became evident during his undergraduate studies, setting the stage for his continued academic success. Currently, he is pursuing his PhD at the same institution, delving deeper into the intersection of neuroscience, computer science, and biomedical engineering. His early education laid a strong foundation for his research in the emerging field of BCI technology.

Professional Endeavors 💼

As a PhD candidate, Wei Liang is already contributing to the rapidly evolving field of Brain-Computer Interfaces, particularly in motor imagery and neural signal processing. His research involves collaboration with prominent experts in the fields of computer science, neuroscience, and biomedical engineering, such as Andrzej Cichocki, Ian Daly, and Brendan Allison. Liang’s professional journey has been shaped by these collaborations, allowing him to gain insights from diverse disciplines, further honing his expertise in BCI.

Contributions and Research Focus 🧠

Wei Liang’s research focuses on advancing Brain-Computer Interface (BCI) technology, particularly in motor imagery and neural signal processing. His work has led to the development of SecNet, a second-order neural network designed to improve motor imagery decoding from electroencephalography (EEG) signals. Liang’s innovative approaches include variance-preserving spatial patterns for EEG signal processing and the use of graph convolutional networks for optimal channel selection. These contributions have enhanced the accuracy and reliability of BCI systems, making them more applicable to real-world scenarios such as stroke rehabilitation and neural engineering.

Impact and Influence 🌍

Wei Liang’s work is making significant strides in improving BCI systems, which have far-reaching applications in medicine, rehabilitation, and human-computer interaction. By optimizing EEG decoding strategies, his research could impact the development of more effective neuroprosthetics and assistive technologies for individuals with motor impairments. His collaboration with leading researchers from around the world further amplifies the global impact of his work, positioning him as a rising star in BCI research.

Academic Citations 📚

Despite being in the early stages of his career, Wei Liang has already made a notable impact on the academic community. His research has led to the publication of five papers, accumulating a total of 14 citations and an h-index of 2. Notable papers include works published in Information Processing & Management, Frontiers in Human Neuroscience, and IEEE Journal of Biomedical and Health Informatics, among others. These publications highlight his contributions to improving BCI systems and their applications.

Technical Skills 🛠️

Wei Liang possesses a strong technical skill set, particularly in the areas of machine learning, neural network architecture, and EEG signal processing. He has expertise in developing novel algorithms for motor imagery decoding, including the use of second-order neural networks and graph convolutional networks. Liang is proficient in various computational tools and programming languages necessary for his research, positioning him as an expert in his field.

Teaching Experience 🏫

Though primarily focused on research, Wei Liang’s academic journey has also included some teaching experience, collaborating with faculty and providing guidance to students. His strong academic background, coupled with his research expertise, allows him to mentor and inspire others in the field of Brain-Computer Interfaces.

Legacy and Future Contributions 🌟

Wei Liang’s research trajectory holds great promise for shaping the future of Brain-Computer Interface technology. His innovative methodologies have the potential to revolutionize how we understand and utilize EEG signals for communication and rehabilitation. In the long term, his contributions could lead to breakthroughs in neuroprosthetics, enhancing the quality of life for individuals with disabilities. With continued dedication and innovation, Liang is on track to leave a lasting legacy in the realm of neuroscience and technology.

Teaching and Mentorship 🧑‍🏫

Although Liang is primarily focused on research, his experiences collaborating with top researchers and participating in academia have enriched his teaching and mentorship skills. His ability to translate complex ideas into understandable concepts makes him an effective communicator, ready to guide the next generation of researchers in the field of BCI.

Awards and Recognition 🏆

Wei Liang has been recognized for his groundbreaking research, publishing in high-impact journals and earning accolades for his contributions to BCI technology. As a promising young researcher, he is poised to receive even greater recognition as his work continues to influence and shape the future of the field.

Top Noted Publications📖

Novel Channel Selection Model Based on Graph Convolutional Network for Motor Imagery
    • Authors: W Liang, J Jin, I Daly, H Sun, X Wang, A Cichocki
    • Journal: Cognitive Neurodynamics
    • Year: 2023
Variance Characteristic Preserving Common Spatial Pattern for Motor Imagery BCI
    • Authors: W Liang, J Jin, R Xu, X Wang, A Cichocki
    • Journal: Frontiers in Human Neuroscience
    • Year: 2023
SecNet: A Second Order Neural Network for MI-EEG
    • Authors: W Liang, BZ Allison, R Xu, X He, X Wang, A Cichocki, J Jin
    • Journal: Information Processing & Management
    • Year: 2025
Multiscale Spatial-Temporal Feature Fusion Neural Network for Motor Imagery Brain-Computer Interfaces
    • Authors: J Jin, W Chen, R Xu, W Liang, X Wu, X He, X Wang, A Cichocki
    • Journal: IEEE Journal of Biomedical and Health Informatics
    • Year: 2024
Leveraging Transfer Superposition Theory for StableState Visual Evoked Potential Cross-Subject Frequency Recognition
    • Authors: X He, BZ Allison, K Qin, W Liang, X Wang, A Cichocki, J Jin
    • Journal: IEEE Transactions on Biomedical Engineering
    • Year: 2024

farnaz shokraneh | personalized medicine | Best Researcher Award

Ms. farnaz shokraneh | personalized medicine | Best Researcher Award

Abo Akademi University, Finland

👨‍🎓Professional Profile 

Orcid Profile

👩‍🔬 Summary

Ms. Farnaz Shokraneh is an experienced pharmaceutical professional currently working as a Doctoral Researcher in Pharmaceutical Development and Medical Technology at Åbo Akademi University in Turku, Finland. With a solid academic background and extensive practical experience in pharmaceutical quality assurance, regulatory compliance, and research, she brings valuable insights into the development of pharmaceutical products and systems. She is committed to advancing personalized medicine and improving quality control in the pharmaceutical industry.

🎓 Education

Ms. Shokraneh holds a Doctor of Pharmacy degree, equivalent to a Finnish Master’s, from Islamic Azad University, Tehran, Iran (2007-2012). She furthered her academic journey with a Master’s in Pharmaceutical Research from Freie Universität Berlin, Germany (2022-2024). Currently, she is pursuing her doctoral research in Pharmaceutical Development and Medical Technology at Åbo Akademi University, Turku, Finland (2022–present).

💼 Professional Experience

Ms. Shokraneh has accumulated extensive experience in various roles within the pharmaceutical industry. She is currently serving as a Quality Manager at CurifyLabs Oy in Helsinki, Finland, since September 2022. Previously, she held the position of Quality Assurance Manager at Mofid Pharma under the license of Bayer Pharmaceutical Company (Dec 2020–Dec 2021). Additionally, she has worked at Modava Pharmaceutical under Novartis (Jul 2018–Jul 2020) and ATI Pharmed Pharmaceutical Co under StragenPharma and CHEMO Pharmaceutical licenses (Apr 2013–Jun 2017).

🛠️ Technical Skills

Ms. Shokraneh’s technical expertise encompasses pharmaceutical development, quality assurance, and regulatory compliance. She is proficient in analytical techniques such as HPLC, mass spectrometry, and micro NIR spectrophotometry. Her experience also extends to pharmacovigilance, safety monitoring, and statistical analysis for pharmaceutical applications, making her highly skilled in ensuring the safety, efficacy, and quality of pharmaceutical products.

🧑‍🏫 Teaching Experience

Although Ms. Shokraneh’s current focus is on research and industry roles, her vast knowledge and experience in the pharmaceutical field allow her to effectively mentor teams and share her expertise. She has contributed to the professional development of her colleagues and participated in educational training programs within the pharmaceutical sector.

🔬 Research Interests

Ms. Shokraneh’s primary research interests lie in pharmaceutical development and medical technology, with a particular focus on personalized medicine. She is passionate about improving drug safety and efficacy through innovations in automated pharmacy compounding, quality control, and exploring new methods for drug delivery and patient-specific treatment plans.

 

📖Top Noted Publications

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets

Authors: Niklas Sandler Topelius, Farnaz Shokraneh, Mahsa Bahman, Julius Lahtinen, Niko Hassinen, Sari Airaksinen, Soumya Verma, Ludmila Hrizanovska, Jana Lass, Urve Paaver et al.

Journal: Pharmaceutics

Year: 2024

A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design

Authors: Farnaz Shokraneh

Journal: Iranian Journal of Pharmaceutical Research

Year: 2014

Comparative Studies of Cytotoxic Manufacturing Practices in Specialized Cancer Centers Against International Guidelines (ASHP, OSHA, HSE-UK)

Authors: Farnaz Shokraneh

Journal: FIP Congress

Year: 2012

Development and Validation of High-Performance Liquid Chromatography for Determination of Nystatin in Pharmaceutical Formulations

Authors: Farnaz Shokraneh

Journal: Research in Pharmaceutical Science

Year: 2012

A New HPLC Method for Determination of Losartan in Human Plasma and Its Application in Bioequivalence Studies

Authors: Farnaz Shokraneh

Journal: Oriental Journal of Chemistry

Year: 2012

Risks to Health Professionals from Hazardous Drugs in Iran: A Pilot Study of Understanding of Healthcare Team to Occupational Exposure to Cytotoxics

Authors: Farnaz Shokraneh

Journal: EXCLI Journal

Year: 2005